TWiV 803: COVID-19 clinical update #79 with Dr. Daniel Griffin
Sep 11, 2021•45 min•Ep. 803
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #79, Daniel Griffin discusses clinical management guidelines, ER visits and hospitalization among children, infection and vaccine induced seroprevalence in the US, antibodies in Kenyan blood donors, infections after vaccination, anticoagulation for thromboprophylaxis, baracitinib efficacy, long-term symptoms in adults, and sustained symptoms after severe disease.
Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Overlooked shortcomings of observational studies (Op For Inf Dis)
- Guidelines for clinical management (Op For Inf Dis)
- ER visits and hospitalization among children (MMWR)
- Hospitalization of adolescents (MMWR)
- Seroprevalence in the US (JAMA)
- Seroprevalence in Kenya (JAMA)
- Infections after vaccine (medRxiv)
- Israel data dashboard
- Guidelines on anticoagulation for thromboprophylaxis (Blood Adv)
- Baricitinib efficacy (Lancet)
- Long term symptoms, US adults (MMWR)
- Severe disease associated with long term symptoms (medRxiv)
- Letters read on TWiV 803
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android